Clinical trial

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

NCT04470310

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-12-31

PhasePHASE4

Study timeline

Study start (actual)2015-12-31Date precision: day

Registry last updated2020-10-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

GlimepirideDRUG · verified · RxNorm: glimepiride

Alogliptin 25Mg TabDRUG

Alogliptin-Pioglitazone 25 Mg-15 Mg Oral TabletDRUG

Sponsors & collaborators

Seoul National University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04470310 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.